Could a simple calculator replace unnecessary prostate biopsies?

NCT ID NCT07422597

Recruiting now Knowledge-focused Sponsor: Norwegian University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two ways to check men with high PSA levels for dangerous prostate cancer: giving everyone an MRI first, or using a risk calculator to decide who needs an MRI and biopsy. The goal is to see if the calculator method catches just as many serious cancers while reducing unnecessary biopsies, MRIs, and anxiety. About 1,000 men with suspected prostate cancer will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Orkdal sjukehus
RECRUITING

Orkanger, Norway
St Olavs Hospital
RECRUITING

Trondheim, 7030, Norway
Sykehuset Levanger
NOT_YET_RECRUITING

Levanger, 7601, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.